Monoclonal Antibodies The approach (s), which is/are currently followed to produce human monoclonal antibodies, is/are known as hybridization of 6-thioguanine-resistant human plasmacytoma with immune human lymphocytes combination of EB Vand hybridoma techniques transformation of antigen specific B lymphocytes (EBV) all of these hybridization of 6-thioguanine-resistant human plasmacytoma with immune human lymphocytes combination of EB Vand hybridoma techniques transformation of antigen specific B lymphocytes (EBV) all of these ANSWER DOWNLOAD EXAMIANS APP
Monoclonal Antibodies Some cross reactions with monoclonal antibodies (MAbs) can occur. Unexpected cross reactions occur more frequently with IgA Ig MAbs IgE IgG IgA Ig MAbs IgE IgG ANSWER DOWNLOAD EXAMIANS APP
Monoclonal Antibodies Preliminary clinical results with a humanized antibody against the interleukin-2 receptor have suggested the poor recognition of immunoglobulin, Ig constant regions All of these presence of HAMA response absence of human immune response against murine proteins (HAMA) response poor recognition of immunoglobulin, Ig constant regions All of these presence of HAMA response absence of human immune response against murine proteins (HAMA) response ANSWER DOWNLOAD EXAMIANS APP
Monoclonal Antibodies The cross linkage of antigens by antibodies is known as complement fixation a cross reaction agglutination all of these complement fixation a cross reaction agglutination all of these ANSWER DOWNLOAD EXAMIANS APP
Monoclonal Antibodies In monoclonal antibody technology, tumor cells that can replicate endlessly are fused with mammalian cells that produce an antibody. The result of this cell fusion is a lymphoblast natural killer cell myeloma hybridoma lymphoblast natural killer cell myeloma hybridoma ANSWER DOWNLOAD EXAMIANS APP
EXAMIANS